1 |
Hagemann GJ WK. The clinical, electrocardiographic and pathological features of cardiac sarcoid. In: Jones Williams W, Davies BH, editors. Sarcoidosis and Other Granulomatous Disorders: Proceedings of the 8th International Conference Cardiff. Cardiff: Alpha & Omega Press; 1980. p.601-6.
|
2 |
Johns CJ, Michele TM. The clinical management of sarcoidosis: a 50- year experience at the Johns Hopkins Hospital. Medicine (Baltimore) 1999;78:65-111.
DOI
ScienceOn
|
3 |
Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977;63:86-108.
DOI
ScienceOn
|
4 |
Hiraga H, Yuwai K, Hiroe M. Guidelines for the Diagnosis of Cardiac Sarcoidosis: Study Report of Diffuse Pulmonary Diseases. Tokyo: Japanese Ministry of Health and Welfare;1993. p.23-4.
|
5 |
Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 2004;83:315-34.
DOI
ScienceOn
|
6 |
Hillerdal G, Nöu E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis: a 15-year European study. Am Rev Respir Dis 1984;130: 29-32.
|
7 |
Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-41.
DOI
ScienceOn
|
8 |
Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-11.
DOI
ScienceOn
|
9 |
Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976;278:455-69.
DOI
|
10 |
Winters SL, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991;18:937-43.
DOI
|
11 |
Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPAenhanced magnetic resonance imaging. Am J Med 2001;110: 520-7.
DOI
ScienceOn
|
12 |
Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002;122:1895-901.
DOI
ScienceOn
|
13 |
Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999;138(2 Pt 1):299-302.
DOI
|
14 |
Ohira H, Tsujino I, Yoshinaga K. 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 2011;38:1773-83.
DOI
ScienceOn
|
15 |
Braun JJ, Kessler R, Constantinesco A, Imperiale A. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 2008;35:1537-43.
DOI
ScienceOn
|
16 |
Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J 2009;157:9-21.
DOI
ScienceOn
|
17 |
Reuhl J, Schneider M, Sievert H, Lutz FU, Zieger G. Myocardial sarcoidosis as a rare cause of sudden cardiac death. Forensic Sci Int 1997;89: 145-53
DOI
ScienceOn
|
18 |
Takada K, Ina Y, Yamamoto M, Satoh T, Morishita M. Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan: clinical evaluation of corticosteroid therapy. Sarcoidosis 1994;11:113-7.
|
19 |
Belhassen B, Pines A, Laniado S. Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis. Chest 1989; 95:918-20.
DOI
ScienceOn
|